Sugi Predict

Sugi Predict / Compounds / SCHEMBL1038436

SCHEMBL1038436

SCHEMBL1038436

CNCCS(=O)(=O)Nc1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 8/20 0.55
▸ ITK Q08881 4/20 0.54
▸ GSK3A P49840 4/20 0.54
▸ EGFR P00533 3/20 0.54
▸ LRRK2 Q5S007 3/20 0.54
▸ AURKA O14965 3/20 0.54
▸ ULK1 O75385 3/20 0.54
▸ CDC7 O00311 3/20 0.54
▸ PLK4 O00444 3/20 0.54
▸ CHEK1 O14757 3/20 0.54
▸ PDPK1 O15530 3/20 0.54
▸ JAK2 O60674 3/20 0.54
▸ ROCK2 O75116 3/20 0.54
▸ PRKD3 O94806 3/20 0.54
▸ PAK4 O96013 3/20 0.54
▸ ABL1 P00519 3/20 0.54
▸ NTRK1 P04629 3/20 0.54
▸ PRKCG P05129 3/20 0.54
▸ INSR P06213 3/20 0.54
▸ LCK P06239 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1038607 0.89 PTK2 (0.52) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1040110 0.88 PTK2 (0.71) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1034417 0.88 EGFR (0.62) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1035859 0.87 PTK2 (0.54) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1035950 0.87 PTK2 (0.54) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1222098 0.85 SYK (0.59) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1220939 0.84 PTK2 (0.55) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL12726312 0.84 LRRK2 (0.57) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1221640 0.84 PTK2 (0.56) PTK2ITKGSK3AEGFRLRRK2
SCHEMBL1038608 0.84 PTK2 (0.57) PTK2ITKGSK3AEGFRLRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098288-A1 SULFONAMIDES AS ZAP-70 INHIBITORS CELLZOME LIMITED (GB) 2011-04-28 — — US claimed
EP-2276747-A1 SULFONAMIDES AS ZAP-70 INHIBITORS Cellzome Limited (GB) 2011-01-26 — — EP claimed
WO-2009112490-A1 SULFONAMIDES AS ZAP-70 INHIBITORS CELLZOME LIMITED (GB) 2009-09-17 — — WO claimed
US-20110098288-A1 SULFONAMIDES AS ZAP-70 INHIBITORS CELLZOME LIMITED (GB) 2011-04-28 — — US disclosed
US-20110098288-A1 SULFONAMIDES AS ZAP-70 INHIBITORS CELLZOME LIMITED (GB) 2011-04-28 — — US disclosed
US-20110098288-A1 SULFONAMIDES AS ZAP-70 INHIBITORS CELLZOME LIMITED (GB) 2011-04-28 — — US disclosed
EP-2276747-A1 SULFONAMIDES AS ZAP-70 INHIBITORS Cellzome Limited (GB) 2011-01-26 — — EP disclosed
WO-2009112490-A1 SULFONAMIDES AS ZAP-70 INHIBITORS CELLZOME LIMITED (GB) 2009-09-17 — — WO disclosed
WO-2009112490-A1 SULFONAMIDES AS ZAP-70 INHIBITORS CELLZOME LIMITED (GB) 2009-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098288-A1 SULFONAMIDES AS ZAP-70 INHIBITORS ZAP70, SYK, LCK PTK2 1495/4885ITK 429/4885GSK3A 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.